Header cover image

South Korean (KOSPI) Life Sciences Industry Analysis

UpdatedAug 11, 2025
DataAggregated Company Financials
Companies28
  • 7D0.8%
  • 3M9.2%
  • 1Y16.3%
  • YTD16.9%

Over the last 7 days, the Life Sciences industry has remained flat, although notably LigaChem Biosciences gained 18%. The past year has been better, since the industry has gained 16% in that time. Earnings are forecast to grow by 16% annually.

Industry Valuation and Performance

Has the South Korean Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 11 Aug 2025₩87.8t₩5.7t₩1.2t16.5x71.7x15.5x
Wed, 09 Jul 2025₩83.4t₩5.6t₩1.2t15.6x67.7x14.9x
Fri, 06 Jun 2025₩82.4t₩5.6t₩1.2t15.4x66.8x14.7x
Sun, 04 May 2025₩87.4t₩5.2t₩1.0t18.2x85.3x16.7x
Tue, 01 Apr 2025₩79.9t₩5.2t₩1.0t17.7x78.7x15.3x
Thu, 27 Feb 2025₩91.9t₩5.0t₩965.6b12.9x95.2x18.3x
Sat, 25 Jan 2025₩86.6t₩5.0t₩965.6b12.9x89.6x17.3x
Mon, 23 Dec 2024₩74.3t₩5.0t₩965.6b12.5x77x14.8x
Wed, 20 Nov 2024₩73.8t₩4.8t₩885.3b12.5x83.4x15.2x
Fri, 18 Oct 2024₩82.5t₩4.8t₩885.3b13.9x93.2x17x
Sun, 15 Sep 2024₩77.4t₩4.8t₩885.3b14x87.5x16x
Tue, 13 Aug 2024₩74.7t₩4.5t₩731.7b15.6x102.1x16.5x
Thu, 11 Jul 2024₩64.4t₩4.5t₩731.7b19.1x88x14.2x
Sat, 08 Jun 2024₩59.3t₩4.6t₩689.6b19.2x86.1x12.9x
Mon, 06 May 2024₩60.7t₩4.4t₩635.1b19.8x95.6x13.9x
Wed, 03 Apr 2024₩64.6t₩4.7t₩656.9b19.3x98.4x13.8x
Fri, 01 Mar 2024₩60.7t₩4.5t₩714.4b34.6x85x13.4x
Sun, 28 Jan 2024₩60.8t₩4.5t₩714.4b34.5x85.1x13.4x
Tue, 26 Dec 2023₩57.1t₩4.5t₩721.5b30.9x79.2x12.6x
Thu, 23 Nov 2023₩56.8t₩4.4t₩647.2b22.7x87.8x12.9x
Sat, 21 Oct 2023₩55.3t₩4.4t₩660.9b27.1x83.7x12.6x
Mon, 18 Sep 2023₩58.3t₩4.4t₩660.9b28.9x88.2x13.3x
Wed, 16 Aug 2023₩62.5t₩4.2t₩673.4b29.2x92.8x14.9x
Fri, 14 Jul 2023₩58.3t₩4.2t₩673.4b29.5x86.6x13.9x
Sun, 11 Jun 2023₩62.3t₩4.2t₩666.5b31.4x93.5x14.7x
Tue, 09 May 2023₩61.7t₩4.1t₩626.3b28x98.5x15.1x
Thu, 06 Apr 2023₩61.4t₩4.1t₩626.3b29.8x98x15x
Sat, 04 Mar 2023₩61.6t₩3.5t₩427.8b21.5x144.1x17.7x
Mon, 30 Jan 2023₩63.1t₩3.5t₩426.6b20.7x147.9x18.1x
Wed, 28 Dec 2022₩64.7t₩3.4t₩428.7b20.4x150.8x18.8x
Fri, 25 Nov 2022₩69.4t₩3.4t₩440.9b22.1x157.3x20.4x
Sun, 23 Oct 2022₩65.6t₩3.0t₩448.5b23.1x146.2x22x
Tue, 20 Sep 2022₩63.3t₩3.0t₩448.5b25.8x141.1x21.2x
Thu, 18 Aug 2022₩68.9t₩2.7t₩454.7b28.7x151.5x25.4x
Price to Earnings Ratio

151.5x


Total Market Cap: ₩68.9tTotal Earnings: ₩454.7bTotal Revenue: ₩2.7tTotal Market Cap vs Earnings and Revenue0%0%0%
South Korean Life Sciences Industry Price to Earnings3Y Average 98.5x202320242025
Current Industry PE
  • Investors are pessimistic on the South Korean Life Sciences industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 71.7x which is lower than its 3-year average PE of 98.5x.
  • The industry is trading close to its 3-year average PS ratio of 15.8x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences industry have grown 39% per year over the last three years.
  • Revenues for these companies have grown 28% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the South Korean Healthcare industry?

KR Market3.17%
Healthcare1.92%
Life Sciences0.81%
Clinical Research and Equipment0.81%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
A141080 LigaChem Biosciences₩149.50k10.2%
+₩500.3b
58.4%PE218x
A087010 Peptron₩300.00k2.0%
+₩139.8b
411.9%PS1627.2x
A445680 Curiox Biosystems₩50.00k20.5%
+₩137.4b
122.2%PS206.1x
A038290 Macrogen₩15.97k5.6%
+₩9.1b
-18.1%PS1.2x
A223250 DreamCIS₩3.56k10.9%
+₩8.3b
-9.3%PE14.8x

Latest News